These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Histologic criteria for classification and differential diagnosis of chronic myeloproliferative disorders. Frisch B; Bartl R; Burkhardt R; Jäger K Haematologia (Budap); 1984; 17(2):209-26. PubMed ID: 6534829 [TBL] [Abstract][Full Text] [Related]
3. Megakaryopoiesis in chronic myeloproliferative diseases. A morphometric evaluation with special emphasis on primary thrombocythemia. Thiele J; Funke S; Holgado S; Choritz H; Georgii A Anal Quant Cytol; 1984 Sep; 6(3):155-67. PubMed ID: 6594964 [TBL] [Abstract][Full Text] [Related]
4. Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis. Michiels JJ; Kutti J; Stark P; Bazzan M; Gugliotta L; Marchioli R; Griesshammer M; van Genderen PJ; Brière J; Kiladjian JJ; Barbui T; Finazzi G; Berlin NI; Pearson TC; Green AC; Fruchtmann SM; Silver RT; Hansmann E; Wehmeier A; Lengfelder E; Landolfi R; Kvasnicka HM; Hasselbalch H; Cervantes F; Thiele J Neth J Med; 1999 Feb; 54(2):46-62. PubMed ID: 10079679 [TBL] [Abstract][Full Text] [Related]
5. Myelofibrosis in chronic myeloproliferative disorders. Incidence among subtypes according to the Hannover Classification. Buhr T; Georgii A; Choritz H Pathol Res Pract; 1993 Mar; 189(2):121-32. PubMed ID: 8321741 [TBL] [Abstract][Full Text] [Related]
6. Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders. Macavei I; Galatâr N Morphol Embryol (Bucur); 1989; 35(2):117-27. PubMed ID: 2529429 [TBL] [Abstract][Full Text] [Related]
7. [Jamshidi biopsy in clinical hematology. Method, indications and results of over 1,000 completed biopsies with special reference to chronic myeloproliferative diseases]. Seewann HL Wien Med Wochenschr Suppl; 1986; 100():1-24. PubMed ID: 3471009 [TBL] [Abstract][Full Text] [Related]
8. [Morphometry of megakaryocytes for supporting the histologic diagnosis of chronic myeloproliferative diseases]. Nafe R; Holgado de Colombo S; Choritz H; Georgii A Pathologe; 1995 Jan; 16(1):34-40. PubMed ID: 7886012 [TBL] [Abstract][Full Text] [Related]
9. Density distribution and size of megakaryocytes in inflammatory reactions of the bone marrow (myelitis) and chronic myeloproliferative diseases. Thiele J; Holgado S; Choritz H; Georgii A Scand J Haematol; 1983 Oct; 31(4):329-41. PubMed ID: 6578591 [TBL] [Abstract][Full Text] [Related]
10. [Diagnosis of chronic myeloproliferative diseases based on bone marrow biopsy]. Matolcsy A; Kónya T; Wéber E Orv Hetil; 1992 Jun; 133(26):1617-20, 1625-6. PubMed ID: 1614699 [TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders. Bock O; Loch G; Schade U; von Wasielewski R; Schlué J; Kreipe H J Pathol; 2005 Apr; 205(5):548-57. PubMed ID: 15726648 [TBL] [Abstract][Full Text] [Related]
12. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders]. Bettini R; Marzetta K; Miglioranza A; Redaelli S; Maino C; Maffiolini A; Gorini M Recenti Prog Med; 2003; 94(7-8):314-20. PubMed ID: 12868237 [TBL] [Abstract][Full Text] [Related]
13. Myeloproliferative disorders. Classification and diagnostic features with special emphasis on chronic myelogenous leukemia and agnogenic myeloid metaplasia. Hyun BH; Gulati GL; Ashton JK Clin Lab Med; 1990 Dec; 10(4):825-38. PubMed ID: 2272176 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic criteria of the myeloproliferative disorders (MPD): essential thrombocythaemia, polycythaemia vera and chronic megakaryocytic granulocytic metaplasia. Michiels JJ Neth J Med; 1997 Aug; 51(2):57-64. PubMed ID: 9286142 [TBL] [Abstract][Full Text] [Related]
15. Abnormalities of megakaryocytes in myelitis and chronic myeloproliferative diseases. Thiele J; Holgado S; Choritz H; Georgii A Virchows Arch B Cell Pathol Incl Mol Pathol; 1982; 41(1-2):67-81. PubMed ID: 6134385 [TBL] [Abstract][Full Text] [Related]
17. Enzyme negative blastic transformation of chronic myeloproliferative disorders: immunophenotyping of the blastic cell population. Matolcsy A; Izer I; Magyarlaki T; Baranyay F Haematologia (Budap); 1991; 24(1):27-37. PubMed ID: 1813360 [TBL] [Abstract][Full Text] [Related]
18. Planimetric analysis of megakaryocytes in the four main groups of chronic myeloproliferative disorders. Nafe R; Georgii A; Kaloutsi V; Fritsch RS; Choritz H Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 61(2):111-6. PubMed ID: 1683718 [TBL] [Abstract][Full Text] [Related]
19. Chronic myeloproliferative diseases on a pathologist's desk--a dilemma of distinct entities versus a clinico-pathologic continuum. A descriptive study based on a material from the Polish population. Rudzki Z; Papla B; Stachura J Pol J Pathol; 2004; 55(1):13-23. PubMed ID: 15195702 [TBL] [Abstract][Full Text] [Related]